| 2A Pharma |
Malmö, Sweden |
Cost effective vaccines and therapeutics based on the AAVLP platform |
| Adverum Biotechnologies |
Menlo Park, CA |
Adeno-Associated Virus Delivery, Gene Therapy |
| Amarna Therapeutics |
Leiden, Netherlands |
Viral Gene Delivery Platform |
| Armata Pharmaceuticals |
Marina del Rey, CA |
Natural and synthetic bacteriophage-based therapies |
| Aura Biosciences |
Cambridge, MA |
Delivery by Pseudo-Viruses |
| CaroGen |
Farmington, CT |
VLV-like Immunotherapy |
| Cold Genesys |
Santa Ana, CA |
Oncolytic Virus |
| DNAtrix |
San Diego, CA |
Oncolytic Virus |
| DNAtrix |
Houston, TX |
Oncolytic Virus |
| Etubics |
Seattle, WA |
Targeted immunotherapies and vaccine products |
| Genelux |
San Diego, CA |
Oncolytic Virus |
| Gritstone Oncology |
Emeryville, CA |
Personalized cancer vaccines |
| Gritstone Oncology |
Cambridge, MA |
Personalized cancer vaccines |
| Icell Kealex Therapeutics |
Houston, TX |
Oncolytic Viruses |
| IGNITE Immunotherapy |
Alameda, CA |
Oncolytic Virus Vaccines |
| Lentigen |
Gaithersburg, MD |
Lentiviral Vector Technology & Services |
| Novavax |
Gaithersburg, MD |
Virus-like Particles, Micelles |
| Oncolytics Biotech |
Calgary, AB |
Human Reovirus Delivery |
| Oncolytics Biotech |
San Diego, CA |
Human Reovirus Delivery |
| Oncorus |
Cambridge, MA |
Cancer Immunotherapy |
| PrimeVax Immuno-Oncology |
Orange, CA |
Dengue Virus combined with autologous dendritic cells |
| Replimune |
Woburn, MA |
Oncolytic immunotherapy |
| Replimune |
Abingdon, UK |
Oncolytic immunotherapy |
| Rocket Pharmaceuticals |
New York, NY |
Gene Therapies |
| Targovax |
Oslo, Norway |
Immuno-oncology |
| Transgene |
Shanghai, China |
Viral Vector Therapeutics, Gene Therapy |
| Transgene |
Illkirch-Graffenstaden, France |
Viral Vector Therapeutics, Gene Therapy |
| Transgene |
Lyon, France |
Viral Vector Therapeutics, Gene Therapy |
| Transgene |
Boston, MA |
Viral Vector Therapeutics, Gene Therapy |
| Turnstone Biologics |
Ottawa, ON |
Oncolytic viral immunotherapy |
| Valo Therapeutics |
Helsinki, Finland |
Oncolytic Virus, Peptide |
| Valo Therapeutics |
Oxford, UK |
Oncolytic Virus, Peptide |
| VCN Biosciences |
Barcelona, Spain |
Oncolytic adenovirus technology platform |
| Vigene Biosciences |
Rockville, MD |
AAV, lentivirus and adenovirus based products and custom services |
| Vir Biotechnology |
San Francisco, CA |
Infectious disease therapies |
| Voyager Therapeutics |
Cambridge, MA |
CNS Gene Therapy |
| Western Oncolytics |
Pittsburgh, PA |
Immuno-oncolytic Therapy |
